StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of CALA opened at $0.00 on Thursday. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- Why Invest in High-Yield Dividend Stocks?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Investing In Preferred Stock vs. Common Stock
- DuPont’s Electronics Spinoff: The Start of Something Big
- What is the Dow Jones Industrial Average (DJIA)?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
